Numeral Ltd (GOLIFE.mu)

Numeral Ltd – Headquartered in the Republic of Mauritius

Industry: Biotech, Health, Pharmaceutical, and Financial Services

Numeral Ltd is a dynamic and forward-looking company based in the Republic of Mauritius, operating at the intersection of biotechnology, health sciences, and financial services. The company continues to innovate across diverse sectors, leveraging its multidisciplinary capabilities to deliver value to shareholders and stakeholders globally.

In the financial year ended 28 February 2025, Numeral Ltd expanded its portfolio with two major acquisitions – Numeral Financial Services (Pty) Ltd and Cryo-Save South Africa (Pty) Ltd – extending its geographic footprint into South Africa and solidifying its cross-border operational strength.

Core business activities include research and development in biotech and pharmaceuticals, as well as a growing suite of financial service offerings under its subsidiaries. The company is committed to identifying high-potential business opportunities across frontier markets, with a clear focus on health innovation, patient outcomes, and financial accessibility.

Market Position: Numeral Ltd is listed on both the Stock Exchange of Mauritius (SEM) and the Johannesburg Stock Exchange (JSE), showcasing its dual-market access and regional strength. With a robust leadership team and an active board, the company is well positioned as a high-growth challenger in Africa’s biotech and financial service markets. Its core competitive strengths include agile acquisitions, investor-friendly governance, and a diversified business model.

Employees: While the specific number of employees is not disclosed in the report, the company’s continued growth and acquisitions signal a positive expansion trend and a likely increase in human capital investments in the near term.

Financial Highlights (from the 2025 Annual Report):

• Revenue: USD 1,692,455 (Group)
• Net Profit: USD 259,005 (Group)
• Total Comprehensive Income: USD 181,944
• Total Assets: USD 2,546,012
• Total Equity: USD 1,526,579
• Cash at Year-End: USD 113,745

Mission Statement: Numeral Ltd is committed to empowering lives through scientific advancement and accessible financial solutions, with a vision to become a pan-African leader in biotechnology and inclusive finance.

Sustainability Focus: Numeral Ltd integrates responsible business practices throughout its operations. Although no dedicated CSR activities were conducted during the 2025 reporting period, the company has embedded sustainability into its risk management, governance, and reporting frameworks. A growing emphasis on operational integrity, transparent reporting, and social accountability positions the group to scale its impact-driven programmes in future financial years.